Subsequently, using the proximity ligation assay (PLA) methodology to detect in situ protein/protein interactions [20], we showed that this pathway, characterized by the formation of ER/Src/PI3K, is present in normal breast tissue and is hyperactivated in aggressive breast tumors [21]. This evidence concerns the gene ESR1 and breast neoplasm.